Page last updated: 2024-08-16

troglitazone and c-peptide

troglitazone has been researched along with c-peptide in 22 studies

Research

Studies (22)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	10 (45.45)	18.2507
2000's	11 (50.00)	29.6817
2010's	1 (4.55)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Beck-Nielsen, H; Berthezene, F; Boulton, AJ; Donoghue, S; Kumar, S; Lettis, S; Muggeo, M; Persson, B; Spinas, GA; Stewart-Long, P	1
Antonucci, TK; Driscoll, JH; Faja, BW; Ghazzi, MN; Huang, SM; Perez, JE; Whitcomb, RW	1
Antonucci, T; Lockwood, D; McLain, R; Norris, RM; Whitcomb, R	1
Eastmond, R; Foot, EA	1
Buchanan, TA; Burant, CF; Cline, G; Gumbiner, B; Hsueh, WA; Inzucchi, S; Kelley, D; Maggs, DG; Nolan, J; Olefsky, JM; Polonsky, KS; Shulman, GI; Silver, D; Valiquett, TR	1
Ghazzi, MN; Horton, ES; Venable, TC; Whitcomb, RW; Whitehouse, F	1
Fonseca, VA; Ghazzi, MN; Huang, SM; Valiquett, TR; Whitcomb, RW	1
Arai, K; Hori, M; Imano, E; Kajimoto, Y; Kanda, T; Motomura, M; Nakatani, Y; Nishida, T; Yamasaki, Y	1
Kruszynska, YT; Mulford, MI; Olefsky, JM; Yu, JG	1
Fujibayashi, K; Ishikawa, S; Itabashi, N; Kawakami, A; Kusaka, I; Nagasaka, S; Nakamura, T; Saito, T	1
Frias, JP; Kruszynska, YT; Olefsky, JM; Yu, JG	1
Fonseca, V; Foyt, HL; Shen, K; Whitcomb, R	1
Akazawa, S; Eguchi, K; Ito, M; Kawasaki, E; Sun, F	1
Adachi, Y; Araki-Sasaki, R; Furuta, M; Gabazza, EC; Hori, Y; Katsuki, A; Murata, K; Sumida, Y; Tsuchihashi, K; Yano, Y	1
Benjasuratwong, Y; Boonyavarakul, A; Bunnag, P; Chandraprasert, S; Chanprasertyotin, S; Deerochanawong, C; Nitiyanant, W; Puavilai, G; Sriussadaporn, S; Suthijumroon, A; Suwanwalaikorn, S	1
Avilés-Santa, ML; Raskin, P; Strowig, SM	1
Grellner, WJ; Harris, WS; Isley, WL; Klein, S; Miles, JM; Windsor, S; Wooldridge, D	1
Bollheimer, LC; Buettner, R; Landauer, H; Schölmerich, J; Troll, S; Wrede, CE	1
Gaillard, T; Habash, D; Osei, K; Rhinesmith, S; Schuster, D	1
Jang, KY; Jang, YB; Kang, KP; Kim, DH; Kim, W; Lee, JE; Lee, S; Moon, SO; Park, SK; Sung, MJ	1
Hanusch-Enserer, U; Kautzky-Willer, A; Ludvik, B; Pacini, G; Prager, R; Tura, A; Wagner, OF; Winzer, C	1
Florez, JC; Goldberg, RB; Jablonski, KA; Kahn, SE; Majithia, AR; Mather, KJ; McAteer, JB	1

Trials

18 trial(s) available for troglitazone and c-peptide

Article	Year
Troglitazone, an insulin action enhancer, improves metabolic control in NIDDM patients. Troglitazone Study Group. Diabetologia, 1996, Volume: 39, Issue:6 Topics: Adult; Aged; Blood Glucose; C-Peptide; Cholesterol; Chromans; Diabetes Mellitus, Type 2; Double-Blind Method; Fasting; Fatty Acids, Nonesterified; Female; Fructosamine; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Leukocyte Count; Lipoproteins, HDL; Lipoproteins, LDL; Male; Middle Aged; Neutrophils; Thiazoles; Thiazolidinediones; Triglycerides; Troglitazone	1996
Cardiac and glycemic benefits of troglitazone treatment in NIDDM. The Troglitazone Study Group. Diabetes, 1997, Volume: 46, Issue:3 Topics: Blood Glucose; C-Peptide; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Chromans; Confidence Intervals; Diabetes Mellitus, Type 2; Echocardiography; Female; Glyburide; Glycated Hemoglobin; Heart; Heart Function Tests; Humans; Hypoglycemic Agents; Insulin; Male; Middle Aged; Stroke Volume; Thiazoles; Thiazolidinediones; Time Factors; Triglycerides; Troglitazone	1997
Impaired glucose tolerance is normalized by treatment with the thiazolidinedione troglitazone. Diabetes care, 1997, Volume: 20, Issue:2 Topics: Adult; Aged; Blood Glucose; C-Peptide; Chromans; Double-Blind Method; Ethnicity; Glucose Intolerance; Glucose Tolerance Test; Humans; Hypoglycemic Agents; Insulin; Middle Aged; Prospective Studies; Thiazoles; Thiazolidinediones; Time Factors; Triglycerides; Troglitazone	1997
Good metabolic and safety profile of troglitazone alone and following alcohol in NIDDM subjects. Diabetes research and clinical practice, 1997, Volume: 38, Issue:1 Topics: Adult; Aged; Blood Glucose; C-Peptide; Chromans; Creatinine; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Interactions; Drug Therapy, Combination; Ethanol; Fasting; Female; Humans; Hydrocortisone; Hypoglycemic Agents; Insulin; Lipids; Male; Middle Aged; Proinsulin; Thiazoles; Thiazolidinediones; Troglitazone	1997
Metabolic effects of troglitazone monotherapy in type 2 diabetes mellitus. A randomized, double-blind, placebo-controlled trial. Annals of internal medicine, 1998, Feb-01, Volume: 128, Issue:3 Topics: Adult; Aged; Analysis of Variance; Blood Glucose; C-Peptide; Chromans; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Glucose; Glucose Clamp Technique; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Liver; Male; Middle Aged; Placebos; Regression Analysis; Thiazoles; Thiazolidinediones; Troglitazone	1998
Troglitazone in combination with sulfonylurea restores glycemic control in patients with type 2 diabetes. The Troglitazone Study Group. Diabetes care, 1998, Volume: 21, Issue:9 Topics: Blood Glucose; Body Weight; C-Peptide; Chromans; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Lipids; Sulfonylurea Compounds; Thiazoles; Thiazolidinediones; Treatment Outcome; Troglitazone	1998
Troglitazone monotherapy improves glycemic control in patients with type 2 diabetes mellitus: a randomized, controlled study. The Troglitazone Study Group. The Journal of clinical endocrinology and metabolism, 1998, Volume: 83, Issue:9 Topics: Aged; Blood Glucose; C-Peptide; Chromans; Diabetes Mellitus, Type 2; Double-Blind Method; Fasting; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Male; Middle Aged; Placebos; Sulfonylurea Compounds; Thiazoles; Thiazolidinediones; Troglitazone	1998
Effect of troglitazone on microalbuminuria in patients with incipient diabetic nephropathy. Diabetes care, 1998, Volume: 21, Issue:12 Topics: Aged; Albuminuria; Blood Glucose; Blood Pressure; C-Peptide; Cholesterol; Cholesterol, HDL; Chromans; Creatinine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Male; Metformin; Middle Aged; Thiazoles; Thiazolidinediones; Triglycerides; Troglitazone	1998
A comparison of troglitazone and metformin on insulin requirements in euglycemic intensively insulin-treated type 2 diabetic patients. Diabetes, 1999, Volume: 48, Issue:12 Topics: Blood Glucose; Body Weight; C-Peptide; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Chromans; Circadian Rhythm; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Drug Therapy, Combination; Fatty Acids, Nonesterified; Female; Fructosamine; Humans; Hypoglycemic Agents; Insulin; Insulin Infusion Systems; Male; Metformin; Middle Aged; Thiazoles; Thiazolidinediones; Triglycerides; Troglitazone	1999
Metabolic effects of troglitazone therapy in type 2 diabetic, obese, and lean normal subjects. Diabetes care, 2000, Volume: 23, Issue:1 Topics: Adult; Blood Glucose; Body Mass Index; C-Peptide; Cholesterol; Chromans; Diabetes Mellitus; Diabetes Mellitus, Type 2; Fatty Acids, Nonesterified; Female; Glucose; Glucose Clamp Technique; Humans; Hypoglycemic Agents; Insulin; Male; Middle Aged; Obesity; Thiazoles; Thiazolidinediones; Troglitazone	2000
Long-term effects of troglitazone: open-label extension studies in type 2 diabetic patients. Diabetes care, 2000, Volume: 23, Issue:3 Topics: Blood Glucose; C-Peptide; Chromans; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Follow-Up Studies; Glyburide; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Lipids; Lipoproteins, HDL; Thiazoles; Thiazolidinediones; Troglitazone	2000
Efficacy of troglitazone on body fat distribution in type 2 diabetes. Diabetes care, 2000, Volume: 23, Issue:8 Topics: Adipose Tissue; Body Mass Index; C-Peptide; Chromans; Diabetes Mellitus; Diabetes Mellitus, Type 2; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Insulin Secretion; Male; Middle Aged; Obesity; Sex Characteristics; Thiazoles; Thiazolidinediones; Tomography, X-Ray Computed; Troglitazone; Viscera; Weight Gain	2000
Effects of troglitazone in patients with type 2 diabetes mellitus not adequately controlled by sulfonylureas. Diabetes research and clinical practice, 2001, Volume: 51, Issue:2 Topics: Adult; Aged; Blood Glucose; Blood Pressure; Body Mass Index; C-Peptide; Chromans; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Middle Aged; Sulfonylurea Compounds; Thailand; Thiazoles; Thiazolidinediones; Time Factors; Troglitazone	2001
Comparison of insulin monotherapy and combination therapy with insulin and metformin or insulin and troglitazone in type 2 diabetes. Diabetes care, 2002, Volume: 25, Issue:10 Topics: Adult; Age of Onset; Aged; Body Mass Index; C-Peptide; Chromans; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Lipids; Lipoproteins; Male; Metformin; Middle Aged; Racial Groups; Texas; Thiazoles; Thiazolidinediones; Troglitazone	2002
Nocturnal and postprandial free fatty acid kinetics in normal and type 2 diabetic subjects: effects of insulin sensitization therapy. Diabetes, 2003, Volume: 52, Issue:3 Topics: Adult; Blood Glucose; C-Peptide; Chromans; Circadian Rhythm; Diabetes Mellitus, Type 2; Fatty Acids, Nonesterified; Female; Food; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Kinetics; Lipolysis; Male; Metformin; Middle Aged; Placebos; Thiazoles; Thiazolidinediones; Troglitazone	2003
The impact of an insulin sensitizer, troglitazone, on glucose metabolism in African Americans at risk for type 2 diabetes mellitus: a placebo-controlled, 24-month randomized study. Metabolism: clinical and experimental, 2003, Volume: 52, Issue:9 Topics: Adult; Black People; Blood Glucose; Body Constitution; Body Mass Index; C-Peptide; Chromans; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Genetic Predisposition to Disease; Glucose Intolerance; Homeostasis; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Lipids; Male; Placebos; Skinfold Thickness; Thiazoles; Thiazolidinediones; Troglitazone	2003
Insulin sensitivity during oral glucose tolerance test and its relations to parameters of glucose metabolism and endothelial function in type 2 diabetic subjects under metformin and thiazolidinedione. Diabetes, obesity & metabolism, 2006, Volume: 8, Issue:5 Topics: Blood Glucose; Body Weight; C-Peptide; Cell Adhesion Molecules; Chromans; Diabetes Mellitus, Type 2; Drug Monitoring; Female; Glucose Tolerance Test; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Male; Metformin; Middle Aged; Proinsulin; Thiazolidinediones; Troglitazone	2006
Association of the SLC30A8 missense polymorphism R325W with proinsulin levels at baseline and after lifestyle, metformin or troglitazone intervention in the Diabetes Prevention Program. Diabetologia, 2011, Volume: 54, Issue:10 Topics: Adult; C-Peptide; Cation Transport Proteins; Chromans; Diabetes Mellitus; Diabetes Mellitus, Type 2; Female; Humans; Insulin; Male; Metformin; Middle Aged; Polymorphism, Genetic; Proinsulin; Thiazolidinediones; Troglitazone; Zinc Transporter 8	2011

Other Studies

4 other study(ies) available for troglitazone and c-peptide

Article	Year
Troglitazone efficacy in a subject with glucocorticoid-induced diabetes. Diabetes care, 1999, Volume: 22, Issue:12 Topics: Aged; C-Peptide; Chromans; Diabetes Mellitus; Female; Glucocorticoids; Humans; Hypoglycemic Agents; Polymyositis; Thiazoles; Thiazolidinediones; Troglitazone	1999
Troglitazone reduces plasma levels of tumour necrosis factor-alpha in obese patients with type 2 diabetes. Diabetes, obesity & metabolism, 2000, Volume: 2, Issue:3 Topics: Blood Glucose; C-Peptide; Chromans; Diabetes Mellitus; Diabetes Mellitus, Type 2; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Obesity; Thiazoles; Thiazolidinediones; Troglitazone; Tumor Necrosis Factor-alpha	2000
Insulin-sparing effects of troglitazone in rat pancreatic islets. Journal of molecular endocrinology, 2003, Volume: 31, Issue:1 Topics: Animals; C-Peptide; Chromans; Gene Expression Regulation; Glucagon; Glucose; Hypoglycemic Agents; In Vitro Techniques; Insulin; Insulin Secretion; Islets of Langerhans; Male; Proglucagon; Proinsulin; Protein Precursors; Rats; Rats, Wistar; RNA, Messenger; Thiazolidinediones; Troglitazone	2003
Rosiglitazone ameliorates cisplatin-induced renal injury in mice. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2006, Volume: 21, Issue:8 Topics: Anilides; Animals; Apoptosis; C-Peptide; Cell Line; Chromans; Cisplatin; Drug Evaluation, Preclinical; Glioma; Humans; Hypoglycemic Agents; Inflammation; Insulin; Intercellular Adhesion Molecule-1; Kidney; Kidney Diseases; Kidney Function Tests; Kidney Tubules, Proximal; Macrophages; Male; Mice; Mice, Inbred C57BL; Monocytes; PPAR gamma; Prostaglandin D2; Protein Transport; Rosiglitazone; Thiazolidinediones; Transcription Factor RelA; Troglitazone; Tumor Necrosis Factor-alpha	2006